Correction to: Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma ; day:20 ; month:3 ; year:2024 ; pages:1
Targeted oncology ; (20.3.2024), 1
- Urheber
-
France, Nicole L.
Blair, Hannah A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11523-024-01053-0
- URN
-
urn:nbn:de:101:1-2405212111305.062631442555
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- France, Nicole L.
- Blair, Hannah A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Mean Platelet Volume and Unresectable Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Correction: Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Mean Platelet Volume and Unresectable Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Correction: Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience
Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Mean Platelet Volume and Unresectable Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Correction: Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience